German Scientist: Second Wave of Coronavirus to Hit World Next Autumn

Hendrik Strech, a German virologist and director of the Institute for Deficiency of Human Immunity Research at Bonn University, said that the next wave of the Coronavirus will hit the northern hemisphere of the world next autumn.

Strech told reporters that if we look at the situation in Australia, then perhaps we will understand how to deal with the Coronavirus.

Wintertime has just started in Australia and other parts of the southern hemisphere. Throughout the cold season scientists see activity of the deadly virus.

Strech pointed out that a few infections were registered in Australia over the past months but now the number is increasing sharply.

The virologist added that one of the reasons for this increase in infection with Coronavirus in Australia, is the start of winter there, warning that a new outbreak of COVID-19 infection could occur in the autumn in the Europe and other parts of the northern hemisphere by the next autumn.

The usual respiratory diseases and corona viruses will be more active when it becomes colder.

Scientists believe that the SARS-CoV-2 virus will also depend on the weather.

When he was asked if he expects a COVID-19 outbreak will occur at the beginning of the autumn, Strech said: "We don't know for sure yet, but there are many statements that make scientists think about it".

Strech went on to say that respiratory viruses spread more quickly when temperatures are lower and the weather is dry or in high humidity.

It can be assumed that CoV-2 will act similarly.

On the other hand, a US health official said the number of novel Coronavirus patients in the United States of America (USA) could be ten times higher and more than 20 million people could be infected with the deadly virus.

Robert Redfield, director of the US Federal Centers for Disease Control and Prevention ( USFCDCP), was quoted as saying: "According to our accurate estimates, there are currently 10 other cases for each registered case."

He stated that between 92-95% of the population of the United States is still vulnerable to infection with the virus, indicating that this evaluation depends upon blood tests for antibodies, because there are 10 antibodies for each A confirmed case of infection.